WO2026108794 - HETEROCYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF
National phase entry is expected:
Publication Number
WO/2026/108794
Publication Date
28.05.2026
International Application No.
PCT/CN2025/135582
International Filing Date
18.11.2025
Title **
[English]
HETEROCYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF
[French]
COMPOSÉ HÉTÉROCYCLIQUE, COMPOSITION PHARMACEUTIQUE ASSOCIÉE ET UTILISATION ASSOCIÉE
[Chinese]
一种杂环化合物、其药物组合物及其应用
Applicants **
SHANGHAI YINGLI PHARMACEUTICAL CO., LTD
Inventors
XU, Zusheng
LOU, Yangtong
Priority Data
202411669602.6
21.11.2024
CN
202510112590.5
24.01.2025
CN
202510536001.6
27.04.2025
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2486 | |
| EPO | Filing, Examination, Granting | 14390 | |
| Japan | Filing, Examination, Granting | 2109 | |
| South Korea | Filing, Examination, Granting | 2049 | |
| USA | Filing, Examination, Granting | 5190 |
Total:
26,224
Contact Us
Abstract[English]
Disclosed herein are a heterocyclic compound, a pharmaceutical composition thereof, and use thereof. The structure of the heterocyclic compound of the present invention is shown in formula I. The heterocyclic compound of the present invention has a strong inhibitory effect on STAT3, and is promising for the treatment and/or prevention of various STAT3-related diseases.[French]
Sont divulgués ici un composé hétérocyclique, une composition pharmaceutique associée et une utilisation associée. La structure du composé hétérocyclique de la présente invention est représentée par la formule I. Le composé hétérocyclique de la présente invention présente un puissant effet inhibiteur sur STAT3 et est prometteur pour le traitement et/ou la prévention de diverses maladies liées à STAT3.[Chinese]
本发明公开了一种杂环化合物、其药物组合物及其应用。本发明的杂环化合物的结构如式I所示。本发明的杂环化合物对STAT3具备很强的抑制作用，有望应用于治疗和/或预防与STAT3相关的多种疾病。